Document ID: chunk:federal_register_of_legislation:F2024L00743:reg:9:p7
Version: federal_register_of_legislation:F2024L00743
Segment Type: reg
Provision Reference: reg 9 (pt 7/8)
Character Range: 22046–25444

neck or chest;
(74)      for brain ischaemia only, inhaling polluted air, for a cumulative period of at least 100 hours, within the 7 days before clinical onset;
Note:  polluted air is defined in the Schedule 1 – Dictionary.
(75)      inhaling chronically polluted air for at least 1000 hours, within the 5 years before clinical onset;
Note: chronically polluted air is defined in the Schedule 1 – Dictionary.
(76)      for intracerebral haemorrhage only, undergoing anticoagulant therapy within the 30 days before clinical onset;
Note: anticoagulant therapy is defined in the Schedule 1 – Dictionary.
(77)      for intracerebral haemorrhage only, taking one of the following antiplatelet drugs on at least 3 days per week for a continuous period of at least 4 weeks before clinical onset, where the last dose was taken no more than 30 days before clinical onset:
(a)          aspirin;
(b)          clopidogrel;
(c)          prasugrel;
(d)          ticagrelor;
(e)          dipyridamole; or
(f)           ticlopidine;
(78)      for intracerebral haemorrhage only, undergoing thrombolytic (fibrinolytic) therapy within the 7 days before clinical onset;
Note: thrombolytic (fibrinolytic) therapy is defined in the Schedule 1 - Dictionary.
(79)      for intracerebral haemorrhage only, having one of the following disorders at the time of clinical onset:
(a)          aplastic anaemia;
(b)          idiopathic thrombocytopaenic purpura or immune thrombocytopaenia;
(c)          disseminated intravascular coagulation;
(d)          essential thrombocythaemia;
(e)          Hodgkin lymphoma;
(f)           inherited or acquired coagulation protein disorder, including haemophilia;
(g)          leukaemia;
(h)          myeloma;
(i)            non-Hodgkin lymphoma;
(j)            post-transfusion purpura;
(k)          qualitative platelet defects associated with coagulation defect;
(l)            thrombocytopaenia; or
(m)        vitamin K deficiency;
(80)      for intracerebral haemorrhage only, bleeding of one of the following intracerebral space occupying lesions at the time of clinical onset:
(a)          abscess;
(b)          cyst;
(c)          neoplasm; or
(d)          tuberculoma;
(81)      for intracerebral haemorrhage only, bleeding from a cerebral aneurysm or a cerebral vascular malformation at the time of clinical onset;
(82)      being sedentary for a cumulative total of at least 10 hours per day on more days than not for at least the 5 years before clinical onset;
Note: being sedentary is defined in the Schedule 1 - Dictionary.
(83)      taking one of the following anti-androgen medications for at least the 6 months before clinical onset:
(a)          androgen receptor blockers, including cyproterone acetate, flutamide and bicalutamide;
(b)          gonadotrophin releasing hormone agonists, including goserelin and leuprorelin; or
(c)          gonadotrophin releasing hormone antagonists, including degarelix;
(84)      having bilateral orchiectomy before clinical onset;
(85)      for brain ischaemia only, having compression of the carotid, vertebral, basilar or cerebral artery at the time of clinical onset;
Note: Examples of a mass or structure that can cause compression include osteophytes associated with cervical spondylosis (especially with rotation of the neck beyond 45 degrees), an abscess, haematoma or neoplasm in the neck.
(86)      taking an antipsychotic